
ChongQing Zhengchuan Pharmaceutical Packaging Co.,Ltd.
SSE:603976.SS
17.35 (CNY) • At close May 14, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 801.122 | 900.649 | 796.198 | 796.657 | 501.982 | 521.081 | 595.781 | 508.682 | 469.995 | 479.684 | 436.034 | 405.802 |
Cost of Revenue
| 635.482 | 759.022 | 629.406 | 592.015 | 373.723 | 379.669 | 424.982 | 347.674 | 319.847 | 349.126 | 302.786 | 290.357 |
Gross Profit
| 165.64 | 141.627 | 166.792 | 204.642 | 128.258 | 141.411 | 170.799 | 161.008 | 150.148 | 130.558 | 133.248 | 115.445 |
Gross Profit Ratio
| 0.207 | 0.157 | 0.209 | 0.257 | 0.256 | 0.271 | 0.287 | 0.317 | 0.319 | 0.272 | 0.306 | 0.284 |
Reseach & Development Expenses
| 20.26 | 23.429 | 19.11 | 12.078 | 8.254 | 5.273 | 2.899 | 0.031 | 20.78 | 24.318 | 16.308 | 0 |
General & Administrative Expenses
| 11.803 | 9.753 | 7.434 | 10.937 | 8.702 | 10.222 | 12.203 | 11.725 | 13.052 | 9.502 | 8.123 | 25.123 |
Selling & Marketing Expenses
| 8.655 | 13.606 | 15.132 | 17.967 | 31.31 | 33.65 | 35.909 | 30.469 | 28.057 | 25.635 | 24.594 | 26.056 |
SG&A
| 20.458 | 23.359 | 22.566 | 28.903 | 40.012 | 43.872 | 48.112 | 42.194 | 41.109 | 35.137 | 32.717 | 51.179 |
Other Expenses
| 59.601 | 49.968 | 39.861 | 34.813 | 27.445 | 32.452 | -0.089 | 0.218 | 4.426 | 2.442 | 3.428 | 1.765 |
Operating Expenses
| 100.319 | 96.756 | 81.537 | 75.794 | 75.711 | 81.597 | 85.733 | 65.718 | 68.453 | 61.596 | 58.054 | 54.72 |
Operating Income
| 65.32 | 44.871 | 93.255 | 122.639 | 61.889 | 71.891 | 94.097 | 96.732 | 79.25 | 68.229 | 76.526 | 61.806 |
Operating Income Ratio
| 0.082 | 0.05 | 0.117 | 0.154 | 0.123 | 0.138 | 0.158 | 0.19 | 0.169 | 0.142 | 0.176 | 0.152 |
Total Other Income Expenses Net
| -5.111 | -0.044 | -34.705 | 3.334 | -0.513 | -0.545 | -0.089 | 0.218 | 3.813 | 1.391 | 3.28 | 1.163 |
Income Before Tax
| 60.209 | 44.827 | 58.55 | 125.973 | 61.376 | 71.346 | 94.008 | 96.95 | 83.066 | 69.62 | 79.806 | 62.969 |
Income Before Tax Ratio
| 0.075 | 0.05 | 0.074 | 0.158 | 0.122 | 0.137 | 0.158 | 0.191 | 0.177 | 0.145 | 0.183 | 0.155 |
Income Tax Expense
| 6.961 | 4.559 | -6.215 | 19.369 | 8.326 | 10.289 | 11.241 | 14.772 | 12.554 | 8.921 | 10.892 | 8.23 |
Net Income
| 53.249 | 40.268 | 64.771 | 106.604 | 53.05 | 61.057 | 82.767 | 82.178 | 70.511 | 60.699 | 68.913 | 54.739 |
Net Income Ratio
| 0.066 | 0.045 | 0.081 | 0.134 | 0.106 | 0.117 | 0.139 | 0.162 | 0.15 | 0.127 | 0.158 | 0.135 |
EPS
| 0.35 | 0.27 | 0.43 | 0.71 | 0.35 | 0.4 | 0.55 | 0.65 | 0.62 | 0.54 | 0.61 | 0.49 |
EPS Diluted
| 0.35 | 0.27 | 0.43 | 0.71 | 0.35 | 0.4 | 0.55 | 0.65 | 0.62 | 0.54 | 0.61 | 0.49 |
EBITDA
| 197.063 | 173.198 | 165.793 | 206.7 | 116.439 | 111.176 | 142.084 | 139.174 | 113.897 | 96.79 | 102.797 | 60.725 |
EBITDA Ratio
| 0.246 | 0.192 | 0.208 | 0.259 | 0.232 | 0.213 | 0.238 | 0.274 | 0.242 | 0.202 | 0.236 | 0.15 |